Clinical Trial Update: The Role of Theophylline Plus Low-dose Formoterol-budesonide in Treatment of Bronchiectasis [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating theophylline in combination with low-dose formoterol-budesonide for bronchiectasis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchiectasis

Drugs mentioned

• Theophylline (Theophylline)
• formoterol-budesonide (formoterol/budesonide)

Snippet

Sponsor: The First Affiliated Hospital of Guangzhou Medical University | Conditions: Bronchiectasis | Phase 4 | Status: COMPLETED